After administering an oral dose of monofluorophosphate (MFP) to human
beings or mts, a fraction of the drug appears in plasma that is bound
to proteins, establishing a previously undetected compartment of nond
iffusible fluoride. This article documents experiments performed in vi
tro, describing the binding of MFP to two plasma globulins: alpha(2)-m
acroglobulin and C3 (a beta-globulin). MFP binds irreversibly to these
proteins through a stable bond. MFP binds to purified alpha(2)-macrog
lobulin or to C3 with a molar ratio MFP: protein close to unity. MFP b
inding reduces significantly the biological activity of these proteins
, which share in common a macrocyclic 4-residue ring thiolactone (Cys-
Gly-GIu-Glu). The binding site of MFP is as yet unknown. Protein-bound
MFP appeared in the plasma of volunteers during the 5-7 hours followi
ng intake. Peak concentration of protein-bound MFP and maximal reducti
on of alpha(2)-macroglobulin activity was observed 2 hours after intak
e. Clearance of protein-bound MFP coincided with the return of alpha(2
)-macroglobulin to basal levels.